Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors
Clinical trial NCT02122770 · COMPLETED
Trial details
- NCT number
- NCT02122770
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-06-05
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.